Tempest Therapeutics
Justin Trojanowski, CPA has a wealth of experience in the accounting field. Justin began their career in 2010 as an Intel Technology Alliances Intern at Dell EMC. In 2012, they joined Ernst & Young (EY) as an Assurance Manager, and was later promoted to Assurance Senior and Assurance Staff. In 2018, they moved to Merck as a Senior Manager, Accounting. In 2019, they joined Nektar Therapeutics as an Associate Director, Accounting. Most recently, in 2022, they began working at Tempest as Corporate Controller and Director, Finance and Assistant Controller.
Justin Trojanowski obtained their B.S. in Accountancy from Providence College in 2011. Justin then went on to earn their MBA in Accountancy from the same institution in 2012. In 2013, they obtained a Certified Public Accountant certification from the Commonwealth of Massachusetts.
This person is not in the org chart
This person is not in any teams
Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.